Moleculin Biotech, Inc.
MBRXA primary-source company identity page built for fast discovery, filing verification and consistent financial research.
A recent price could not be verified. Check the exchange before trading.
Four checks before any decision
Business model
Understand how the company earns and where demand originates.
Revenue and margin
Compare equivalent periods; separate growth from profitability.
Debt and cash flow
Test balance-sheet resilience and cash conversion.
Valuation and risk
Use sector peers, scenarios and explicit risk limits.
Company calendar
Moleculin 1-for-20 reverse split effective
Moleculin's 1-for-20 reverse split takes effect October 20 at 12:01 AM US Eastern time. Cash is payable instead of fractional shares. Par value remains $0.001 per share and authorized common shares remain 500 million.
Moleculin ↗Moleculin split-adjusted trading begins
Moleculin shares begin trading on a 1-for-20 reverse-split-adjusted basis at the October 20 Nasdaq open. The symbol remains MBRX; the new CUSIP is 60855D507. Trading starts separately from the legal effective time of 12:01 AM US Eastern that day.
Moleculin ↗More NASDAQ records
Alphabetically adjacent directory records for faster navigation; this is not a peer or valuation classification.
Checking SEC financial statements
A dash means standardized data is unavailable. Always check the filing period, currency and accounting scope.